Affymetrix, Inc. (NASDAQ: AFFX, "Affymetrix" or "the Company") today announced that the Company's Board of Directors (the "Board"), in consultation with its legal and financial advisors, has determined that the unsolicited...

Affymetrix, Inc. (NASDAQ: AFFX, "Affymetrix" or the "Company") today announced that the Company's Board of Directors has informed Origin Technologies Corporation, LLC ("Origin") that the Company will engage in discussions...

Affymetrix (AFFX) stock is climbing in early-morning trading after the company said a takeover proposal by Origin could lead to a "superior proposal" compared to Thermo Fisher Scientific's (TMO) offer.

Affymetrix, Inc. (NASDAQ:AFFX, "Affymetrix" or the "Company") today announced that the Company's Board of Directors, in consultation with its legal and financial advisors, has determined that the new unsolicited merger...

Affymetrix Inc. (NASDAQ: AFFX) Affymetrix announced that it has reviewed the proposal made by Origin Technologies Corporation, LLC ("Origin") on March 18 for a transaction in which the stockholders of Affymetrix would...

Affymetrix Inc. (NASDAQ:AFFX) today announced that it has received a grant from Innovate UK (IUK) to demonstrate the health and economic value of utilizing the company's OncoScan ® FFPE Assay Kit for non-invasive...

Affymetrix, Inc. (NASDAQ:AFFX) announced today that one of the world's largest producers of breeding chickens - Roussay, France-based Groupe Grimaud - will use the Axiom ® genotyping platform from Affymetrix in...